K. Ilker Sen
K. Ilker Sen publishes mostly in Molecular Biology, Spectroscopy and Cardiology and Cardiovascular Medicine, on topics such as Protein purification and stability, Biosimilars and Bioanalytical Methods and Mass Spectrometry Techniques and Applications.
- World rank
- #2,943,461 of 7,710,434 ranked researchers
- Rank in United States
- #847,664 of 1,627,098
- Works
- 21
- Citations
- 681
- Citations per work
- 32.4
What does K. Ilker Sen research?
K. Ilker Sen's work is mostly in Biochemistry, Genetics and Molecular Biology (44%), Chemistry (16%), Medicine (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1152.3%
- Everything else419.1%
- Physical Sciences315.9%
- Chemistry315.9%
- Health Sciences312.7%
- Medicine312.7%
- 1Molecular Biology36% of their works
- 2Spectroscopy16% of their works
- 3Cardiology and Cardiovascular Medicine8% of their works
- 4Biophysics8% of their works
- 5Immunology8% of their works
- 6Radiology, Nuclear Medicine and Imaging5% of their works
Research topics
- Protein purification and stability
- Biosimilars and Bioanalytical Methods
- Mass Spectrometry Techniques and Applications
- Electron Spin Resonance Studies
- Advanced Proteomics Techniques and Applications
- Cardiomyopathy and Myosin Studies
- Viral Infectious Diseases and Gene Expression in Insects
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe K. Ilker Sen's research?
The keywords of their largest research topics: Monoclonal Antibodies, Biopharmaceuticals, Immunogenicity, Therapeutic Antibodies, Mass Spectrometry, Proteomics, Protein Aggregation and Recombinant Proteins.
- Mammalian Cells
- Antibody Engineering
- Protein Identification
- Electron Spin Resonance
- Cardiomyopathies
- Electrospray
- Bioanalytical Methods
- Recombinant Proteins
- Proteomics
- Therapeutic Antibodies
- Biopharmaceuticals
- Monoclonal Antibodies
- Immunogenicity
- Mass Spectrometry
- Protein Aggregation
- Glycosylation
- Biosimilars
- Ionization
- Distance Measurements
- Genetic Mutations
- Quantitative Analysis
- Fc Receptors
- Recombinant Protein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Monoclonal Antibodies163 topics
- Biopharmaceuticals132 topics
- Immunogenicity132 topics
- Therapeutic Antibodies112 topics
- Mass Spectrometry92 topics
- Proteomics92 topics
- Protein Aggregation81 topic
- Recombinant Proteins81 topic
- Glycosylation62 topics
- Bioanalytical Methods51 topic
- Biosimilars51 topic
- Electrospray51 topic
- Ionization51 topic
- Cardiomyopathies41 topic
- Distance Measurements41 topic
- Electron Spin Resonance41 topic
- Genetic Mutations41 topic
- Protein Identification41 topic
- Quantitative Analysis41 topic
- Antibody Engineering31 topic
- Fc Receptors31 topic
- Mammalian Cells31 topic
- Recombinant Protein31 topic
Where does K. Ilker Sen work?
K. Ilker Sen's main affiliation in the publication record is Protein Metrics (United States), United States.
How many publications and citations does K. Ilker Sen have?
OpenAlex counts 21 works and 681 citations for K. Ilker Sen, an h-index of 12, ranking #2,943,461 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about K. Ilker Sen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.